Search - tctmd.com

Displaying 601 - 614 of 614

Sort: Relevancy | Date

Video

» Live Case

Cedars Sinai Medical Center, Los Angeles, CA - Mitral TEER in Primary MR (PRIMARY Trial)

November 21, 2023

Video

» Live Case

Cedars Sinai Medical Center, Los Angeles, CA - ViV – Balloon Expandable TMVR

November 17, 2023

TAVR for Aortic Regurgitation: The Completion of the ALIGN-AR Study and the Future Paradigm of AR Treatment

Partner Content

TAVR for Aortic Regurgitation: The Completion of the ALIGN-AR Study and the Future Paradigm of AR Treatment

October 10, 2022

Video

» Live Case

Structural Heart Disease 11 - Cedars - Sinai Medical Center - Los Angeles CA

November 6, 2021

Video

» Live Case

Structural Heart Disease 9 - Cedars - Sinai Medical Center - Los Angeles CA

November 6, 2021

PLX Pharma - Aspirin for the Interventionalist: More Than Meets the Eye

CME

Aspirin for the Interventionalist: More Than Meets the Eye

Contrast-Induced Acute Kidney Injury: Preventive Measures that Work in High Risk Patients - Osprey/Abiomed

Partner Content

Contrast-Induced Acute Kidney Injury: Preventive Measures that Work in High Risk Patients - Osprey/Abiomed

November 12, 2019

Partner Content

Building Your TAVR Program - Medtronic

October 31, 2019

Partner Content

FFRangio and the Rise of Image-Based Fractional Flow Reserve (FFR) - CathWorks

October 29, 2019

Video

» Live Case

SHDS 2018: Live Cases #8: Cedars-Sinai Medical Center, Los Angeles, CA - Mitral/Tricuspid

June 26, 2018

Video

» Live Case

SHDS 2018: Live Case #5: Cedars-Sinai Medical Center, Los Angeles, CA - TAVR

June 26, 2018

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

CME

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

CME

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.